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Uropathogenic Escherichia coli (UPEC) of sequence type 131 (E. coli ST131) are a pandemic 30 
multidrug resistant clone associated with urinary tract and bloodstream infections. Type 1 31 
fimbriae, a major UPEC virulence factor, are essential for ST131 bladder colonization. The 32 
globally dominant sub-lineage of ST131 strains, clade C/H30-R, possess an ISEc55 insertion in 33 
the fimB gene that controls phase-variable type 1 fimbriae expression via the invertible fimS 34 
promoter. We report that the inactivation of fimB in these strains causes altered regulation of type 35 
1 fimbriae expression. Using a novel molecular approach, we demonstrate that ‘off’ to ‘on’ fimS 36 
inversion is reduced in these strains and mediated by the fimE and fimX genes. Unlike typical 37 
UPEC strains, the nucleoid-associated H-NS protein does not strongly repress fimE transcription 38 
in these strains. Using a genetic screen to identify novel regulators of fimE and fimX in the clade 39 
C/H30-R ST131 strain EC958, we defined a new role for the guaB gene as a regulator of type 1 40 
fimbriae and a mouse bladder colonization factor. Our results provide a comprehensive analysis 41 
of type 1 fimbriae regulation in the globally predominant group of ST131 strains, and highlight 42 
important differences in its control compared to non-ST131 UPEC.   43 




Uropathogenic Escherichia coli (UPEC) are the leading cause of urinary tract infection (UTI), 45 
resulting in over 150 million cases worldwide every year (1) and amounting to billions of dollars 46 
spent in direct and associated healthcare costs (2). The increased incidence of UTIs caused by 47 
multidrug resistant (MDR) strains, including strains that belong to high-risk globally pandemic 48 
clones such as E. coli sequence type 131 (E. coli ST131), presents significant new challenges for 49 
the management and treatment of UTI.  50 
 51 
E. coli ST131 is a globally disseminated MDR clone originally identified due to its close 52 
association with the spread of the blaCTX-M-15 extended spectrum β-lactamase (ESBL) gene (3-5). 53 
Genomic analysis of E. coli ST131 has identified a globally dominant fluoroquinolone resistant-54 
fimH30 subgroup previously defined as H30-R (6) or clade C (7), as well as two additional less 55 
prevalent clades (referred to as A and B) (7). Type 1 fimbriae represent the best-characterized E. 56 
coli ST131 virulence factor and are required for ST131 colonization of the mouse bladder (8). Its 57 
pharmacological inhibition has been shown to prevent the establishment of acute MDR UTI and 58 
treat chronic bladder infection in mice (9).  59 
 60 
The E. coli type 1 fimbriae (fim) gene cluster contains nine genes, which encode the major (FimA) 61 
and minor (FimFGH) structural components, the chaperone-usher transport and assembly apparatus 62 
(FimCD) and two regulatory proteins (FimB and FimE) (10, 11). Type 1 fimbrial expression is 63 
phase variable due to inversion of the fim switch (fimS), a 314 bp invertible DNA element which 64 
contains a promoter that drives transcription of the fimACDFGH genes (12). ‘On’ or ‘off’ 65 
orientation of fimS results in a fimbriated or bald phenotype, respectively. Two tyrosine-like 66 
Page 5 of 62 Molecular Microbiology
For Peer Review
 5 
recombinases, FimB and FimE, catalyze the inversion of fimS (13). The FimB recombinase 67 
possesses bidirectional switching activity (‘off’-to-‘on’ and ‘on’-to-‘off’), while FimE primarily 68 
catalyzes ‘on’-to-‘off’ fimS inversion (13, 14). FimE can also mediate ‘off’-to-‘on’ inversion of fimS 69 
under some growth conditions, but at lower efficiency (15, 16). The transcription of the fimB and 70 
fimE genes is driven by individual promoters, both of which are repressed by the histone-like 71 
nucleoid associated protein H-NS in E. coli K-12 strains (17). The inversion of fimS is subject to a 72 
complex regulatory network that involves several other global regulators, including integration host 73 
factor (IHF) (18) and the leucine-responsive regulatory protein (Lrp) (19), as well as other proteins 74 
that directly or indirectly impact on fimS orientation (reviewed in (20)). The ‘off’-to-‘on’ switching 75 
of fimS is enhanced by growth in static liquid culture, which results in the enrichment of type 1 76 
fimbriated cells and the formation of a pellicle at the air-liquid interface (21-23). 77 
 78 
In addition to fimB and fimE, three other genes encoding tyrosine-like recombinases have been 79 
identified in UPEC (24). The products of two of these genes, FimX (24-26) and IpuA (24) can 80 
mediate fimS inversion. It has been shown that FimX possesses specificity for fimS ‘off’ to ‘on’ 81 
inversion, while IpuA can mediate bidirectional inversion (24, 26). In the reference UPEC strain 82 
UTI89, FimX mediates slow ‘off’ to ‘on’ fimS inversion in vitro, but rapid fimS ‘on’ switching 83 
during infection of the mouse bladder (25). The fimX gene is located adjacent to the hyxR gene at a 84 
site distal to the fim genes on the chromosome (25, 27). An invertible DNA switch analogous to 85 
fimS lies between the fimX-hyxR genes (27). FimX-mediated inversion of this in cis cognate 86 
switch influences the transcription of hyxR, which encodes a LuxR-like response regulator that 87 
controls tolerance to reactive nitrogen intermediates (27). 88 
 89 
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E. coli ST131 strains from the globally dominant clade C/H30-R group (hereafter referred to as 90 
clade C) possess a 1,895bp insertion element within the fimB recombinase gene (fimB::ISEc55; 91 
Fig. 1) (8, 28). Given the role of fimB in fimS ‘on’ switching, it is therefore likely that the 92 
presence of this insertion affects type 1 fimbriae expression in ST131. Indeed, the fimB::ISEc55 93 
insertion in ST131 has been associated with a slower ‘off’-to-‘on’ switching phenotype in vitro 94 
(8). 95 
 96 
In this study, we investigated the impact of the fimB::ISEc55 insertion on type 1 fimbriae 97 
expression by comparing ST131 strains that possessed either an intact or disrupted fimB gene. 98 
We confirmed that strains containing the fimB::ISEc55 insertion display slow ‘off’ to ‘on’ type 1 99 
fimbriae switching phenotype and demonstrated its association with increased transcription of 100 
the fimE gene. Notably, H-NS repression of fimE in these strains was also altered compared to 101 
non-ST131 strains, highlighting an important difference in type 1 fimbriae regulation between 102 
ST131 strains and other well-characterized UPEC reference strains. We also examined the role 103 
of the FimE and FimX recombinases in fimS inversion in the ST131 clade C reference strain 104 
EC958, and described the use of a novel molecular approach based on Illumina deep sequencing 105 
to quantitate fimS orientation. Finally, we show that in EC958, guanosine 5' triphosphate (GTP) 106 
homeostasis and the bacterial stringent response triggered by the (p)ppGpp alarmone contribute 107 
to type 1 fimbriae expression via fimE and fimX regulation.   108 




Most E. coli ST131 strains can express type 1 fimbriae regardless of their fimB status  110 
We previously sequenced a large collection of E. coli ST131 isolates from different geographical 111 
locations (7), including the high-quality reference genome of EC958, a representative clade C 112 
strain (8, 29). Despite most strains encoding intact and seemingly functional type 1 fimbriae 113 
operons, type 1 fimbriae expression was not a conserved trait among E. coli ST131 strains under 114 
standard laboratory growth (7, 8). This variability in type 1 fimbriae expression was significantly 115 
associated with the presence of an insertion element within the fimB recombinase gene that was 116 
identified in most clade C ST131 strains studied by us and others (7, 8, 28). Here, we extended 117 
these findings in a larger collection of 91 ST131 strains (71 previously published, detailed in 118 
Materials and Methods) for which we provide a comprehensive type 1 fimbriae expression 119 
profile. In this collection, 57 strains contained the fimB::ISEc55 insertion (and were from clade 120 
C) and 34 contained an intact fimB gene (and were from clades A and B). Using yeast cell 121 
agglutination, a standard method for monitoring the production of mannose-sensitive fimbriae 122 
(30), we determined type 1 fimbriae expression following growth in different conditions (Table 123 
1). Following overnight shaking growth in LB broth at 37°C, only 14% of the fimB::ISEc55 124 
containing strains expressed type 1 fimbriae compared to 70.6% of strains with an intact fimB 125 
gene, X2 (1, N = 91) = 29.87,  P<0.0001. This significant difference was also observed following 126 
overnight static growth, X2 (1, N = 91) = 9.063, P<0.01, but no significant association was seen 127 
between fimB status and type 1 fimbriae expression when strains were further statically 128 
subcultured (Table 1; days 2 and 3). By three successive rounds of static subculture, the majority 129 
of ST131 strains were positive for type 1 fimbriae expression irrespective of fimB gene status. 130 
However, a step-wise increase in the proportion of type 1 positive strains was only seen for those 131 
Page 8 of 62Molecular Microbiology
For Peer Review
 8 
containing the fimB::ISEc55 insertion, suggesting a slower rate of ‘on’ switching for most of 132 
these strains. 133 
 134 
In our analysis, ten strains (five with an intact fimB and five with a fimB::ISEc55 insertion) 135 
remained negative for type 1 fimbriae expression and were further subjected to six additional 136 
rounds of 24-hour static subculture. This resulted in the expression of type 1 fimbriae by four 137 
strains, three out of which had an intact fimB gene. Of the six remaining strains (S1, S18, S27, 138 
S36, S61, S77), S36 (Supporting Information Fig. S1) and S77 (7) had large deletions within 139 
coding regions of the type 1 fimbrial operon, accounting for their negative yeast agglutination 140 
phenotype. To test the capacity of fimS to invert to an ‘on’ orientation in S1, S18, S27 and S61, 141 
each strain was transformed with a plasmid containing the fimB gene from CFT073 (pFimB) and 142 
subjected to static culture followed by a screening PCR to determine fimS orientation (24). Over-143 
expression of FimB in this manner resulted in fimS inversion to an ‘on’ orientation in three of the 144 
strains (S1, S18 and S61), however functional type 1 fimbriae expression as assessed by yeast 145 
cell agglutination could only be detected for S18 (Table 2). Sequence analysis of fimS from S27 146 
revealed a single cytosine deletion (Supporting Information Fig. S2) 8bp downstream of the left 147 
inverted repeat in fimS (31), which may account for the ‘locked off’ status of fimS in this strain. 148 
 149 
The transcription of fimE is enhanced in ST131 strains with a fimB::ISEc55 insertion  150 
We hypothesized that the fimB::ISEc55 insertion may alter the transcription of the downstream 151 
fimE recombinase gene. In order to test this, we examined the level of fimE transcription using 152 
qRT-PCR in EC958 as well as four additional clade C ST131 strains with the same fimB::ISEc55 153 
insertion (S4, S54, S60, S88), and compared this to the level of fimE transcription in four ST131 154 
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strains with an intact fimB gene (S17, S31, S55, S90). Strains were grown in M9 minimal 155 
glucose medium with aeration to mid-log phase for analysis. In all cases, the level of fimE 156 
transcription was significantly higher in strains with the fimB::ISEc55 insertion compared to 157 
strains with an intact fimB gene (overall 6.26-fold increase in fimE; Fig. 2A; P<0.05).  158 
 159 
FimX is another accessory tyrosine recombinase that contributes to turning ‘on’ fimS in UPEC 160 
(32). Given that all nine ST131 strains used for this analysis also screened positive for the fimX 161 
gene by PCR, fimX transcript levels were also examined. There was no significant difference in 162 
fimX transcription between the two strain sets (Fig. 2B).  163 
 164 
The fimB::ISEc55 insertion does not contain an additional fimE promoter  165 
The transcription start site (TSS) of fimE has previously been mapped to a T residue 166 bases 166 
upstream of the GTG start codon in the E. coli K-12 strain VL751 (17). As we observed 167 
significantly higher fimE transcript levels in ST131 strains with the fimB::ISEc55 insertion, we 168 
hypothesized that there may be an additional promoter located within the insertion element that 169 
could drive fimE transcription. The fimE TSS was mapped using 5' RACE to a G residue 164 170 
bases upstream of the start codon in all five of the fimB::ISEc55 ST131 strains tested (EC958, 171 
S4, S54, S60, S88; Fig. 3). As a control, we also mapped the TSS of fimE in one ST131 strain 172 
with an intact fimB gene (S90), and showed that it was identical. A consensus -35 (TTGTTA) 173 
and -10 (AAAATA) promoter sequence, separated by 18 bp, was conserved in all ST131 strains 174 
examined.  175 
 176 
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Since the TSS was conserved in all ST131 strains tested, consensus sequences of fimE promoter 177 
and coding regions (1074 bp) from clades A, B and C strains were constructed from previously 178 
published genome sequences (7) to ascertain if there were any differences that could explain the 179 
higher fimE transcription observed in clade C strains. These were compared to corresponding 180 
fimE sequences from two non-ST131 UPEC strains (CFT073 and UTI89) and E. coli K-12 strain 181 
MG1655 by multiple sequence alignment (Supporting Information Fig. S3). Sequences from 182 
ST131 clade A and C strains were 100% identical and closely related to fimE from MG1655. In 183 
contrast, the sequence of the fimE promoter and coding region from ST131 clade B strains 184 
contained several nucleotide changes, and was most similar to the corresponding sequence from 185 
CFT073 and UTI89. The most parsimonious explanation for our observation in light of the 186 
known phylogeny of ST131 (7) is an independent recombination in the fimE region of clade B 187 
strains after divergence from clade C. This is distinct from the previously reported fimD-uxuR 188 
recombination event in clade C that encompassed the fimH30 allele (28). Nucleotide changes in 189 
the coding region were synonymous with only a single amino acid substitution (V198A) found in 190 
FimE from clade B ST131 strains (also present in UTI89, Supporting Information Fig. S3). 191 
These changes, however, are unlikely to account for the increased fimE transcript levels observed 192 
in strains with the fimB::ISEc55 insertion, as this is exclusively found in clade C ST131 strains.  193 
 194 
FimE and FimX are responsible for inverting fimS to the ‘on’ orientation in EC958  195 
Despite the lack of an intact fimB gene, the majority of clade C ST131 strains still expressed 196 
functional type 1 fimbriae after multiple rounds of static growth, indicating that they possess an 197 
alternative recombinase capable of switching ‘on’ fimS. Based on genomic analysis, EC958 198 
contains two tyrosine-like recombinase genes that have been shown to mediate inversion of fimS 199 
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in other E. coli strains; namely fimE (15) and fimX (24-26). We therefore constructed a series of 200 
isogenic mutants in EC958 lacking fimE (EC958fimE), fimX (EC958fimX) or both genes 201 
(EC958fimE fimX) and monitored their capacity to express type 1 fimbriae by yeast agglutination 202 
and western blot analysis (using an antibody against the major fimbrial subunit FimA) following 203 
static growth with repeated subculture over a period of 5 days (Fig. 4).  204 
 205 
Type 1 fimbriae expression was detected in EC958 following 3 successive rounds of 24-hour 206 
static growth. In contrast, type 1 fimbriae expression by EC958fimE was delayed and only 207 
observed after 4 successive rounds of static growth, demonstrating a direct role for FimE in ‘off’ 208 
to ‘on’ fimS inversion (Fig. 4A). This also implicated a role for FimX in fimS inversion, and 209 
although the single EC958fimX mutant demonstrated a type 1 fimbriae expression profile 210 
identical to wild-type, the EC958fimE fimX double mutant failed to express type 1 fimbriae after 211 
prolonged static subculture for up to 5 days (Fig. 4A). This result was further validated by 212 
complementation of the EC958fimE fimX double mutant with a plasmid containing either fimE or 213 
fimX (pFimE or pFimX), both of which resulted in rapid type 1 fimbriae production within two 214 
days of static subculture (Fig. 4B). Thus, our data demonstrate that FimE is the major 215 
recombinase responsible for ‘off’ to ‘on’ fimS inversion in EC958, and that FimX can also 216 
mediate this switching mechanism, albeit less efficiently than FimE during in vitro static growth. 217 
  218 
Direct quantitation of fim switching in EC958 using Illumina sequencing  219 
In order to quantitate the efficiency of FimE- and FimX-mediated fimS inversion in EC958, we 220 
utilized a novel read-mapping method based on Illumina sequencing data that we refer to as 221 
DNA Invertible Switch Counter (or DISCus). EC958, EC958fimE and EC958fimX were grown 222 
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under static conditions as described in the previous section. Aliquots from the air-liquid interface 223 
of each subculture were harvested on days 1-5, and genomic DNA was extracted and sequenced 224 
using Illumina Technology. Using DISCus, we determined the percentage of reads that 225 
corresponded to either the ‘on’ or ‘off’ orientation of fimS at each time point by read mapping to 226 
fimS pseudo-reference sequences representing both orientations. The starting inoculum for these 227 
experiments was an overnight shaking culture, which possessed only 1% fimS ‘on’ reads. In the 228 
static subculture time course, EC958 produced a steadily increasing fimS ‘on’ switching profile, 229 
with a maximum of 71% ‘on’ reads at day 5 (Fig. 5A). EC958fimX produced a similar fimS 230 
switching profile, with the exception that ‘on’ switching was slower on day 2 compared to wild-231 
type (Fig. 5A). In contrast, fimS ‘on’ switching in EC958fimE occurred at a significantly slower 232 
rate. Only 11.6% of ‘on’ reads were detected at day 4 of static subculture, which then increased 233 
to a level comparative to EC958 and EC958fimX at day 5. DISCus analysis of the EC958fimE 234 
fimX double mutant did not identify any significant fimS ‘on’ switching, supporting our 235 
observation that FimE and FimX are the only recombinases capable of inverting fimS in EC958. 236 
Overall, the quantitative fimS switching data closely paralleled the type 1 fimbriae expression 237 
analysis for each strain based on yeast agglutination and FimA protein production (Fig. 4). 238 
 239 
To examine the specificity of FimE and FimX for fimS inversion in greater detail, we 240 
complemented the EC958fimE fimX double mutant by introduction of a plasmid containing fimE 241 
(pFimE) or fimX (pFimX). The EC958fimE fimX (pSU2718, empty vector control), EC958fimE 242 
fimX(pFimE) and EC958fimE fimX(pFimX) strains were subcultured by static growth over 3 243 
days as described above, and DISCus was used to analyze the fimS orientation from Illumina 244 
sequences generated at each time point. Interestingly, data from these experiments demonstrated 245 
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that when the recombinases were over-expressed in this manner, FimX exhibited greater 246 
propensity for fimS ‘off’ to ‘on’ inversion than FimE (Fig. 5B).   247 
 248 
FimE does not invert the fimX switch in EC958 249 
The fimX switch, located between the fimX-hyxR genes, comprises two 16 bp inverted repeats 250 
flanking a 278 bp central region (27). In addition to mediating in trans inversion of fimS (27), 251 
FimX also mediates in cis bidirectional inversion of this switch. To assess this in greater detail, 252 
we analyzed the fimX switch inversion rate from the sequence data generated above. In the 253 
experiments that involved repeated static subculture of EC958, EC958fimE and EC958fimX, the 254 
fimX switch remained primarily in the ‘off’ orientation (92-97% ‘off’) throughout the 5-day 255 
static subculture period (Fig. 6A). However, in the experiments involving subculture of the 256 
complemented strains EC958fimE fimX(pFimE) and EC958fimE fimX(pFimX), and the control 257 
strain EC958fimE fimX(pSU2718), we observed very rapid FimX-mediated fimX switch 258 
inversion within a day (Fig. 6B). Taken together, these results demonstrate a rapid and strong 259 
interaction of FimX with its cognate switch. Furthermore, these results also demonstrate for the 260 
first time that FimE is unable to invert the fimX switch in EC958. 261 
 262 
H-NS is not a major repressor of fimE gene expression in EC958 263 
The histone-like nucleoid structuring protein (H-NS) is a global transcriptional regulator (33). H-264 
NS has been shown to directly regulate type 1 fimbriae expression in E. coli K-12 by binding to 265 
sequences adjacent to and within fimS (34) and also to the promoters of fimB and fimE (17, 35). 266 
At 37°C, H-NS down-regulates fimE transcription and hns deletion leads to increased fimE 267 
promoter activity (35). We constructed a hns deletion in EC958 and three non-ST131 UPEC 268 
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strains (UTI89, 536 and IHE3034) and measured fimE transcript levels of all wild-type strains 269 
and corresponding hns mutants by qRT-PCR. At 37°C, deletion of hns led to significantly 270 
increased fimE transcription compared to the wild-type in all non-ST131 UPEC strains (Fig. 7B-271 
D). However, in EC958, there was only a relatively small increase in fimE transcription in the 272 
hns mutant compared to the wild-type (Fig. 7A). Thus, H-NS does not strongly repress fimE 273 
transcription in EC958. 274 
 275 
Identification of genes that affect fimE and fimX promoter activity in EC958 276 
In order to investigate the regulation of the fimE and fimX genes in EC958, two promoter-277 
reporter strains were generated. The lacIZ genes of EC958 were initially inactivated to generate 278 
strain EC958lac, and this strain was subsequently modiﬁed by inserting the lacZ gene as a 279 
chromosomally located transcriptional fusion to the fimE (EC958fimE::lacZ) or fimX 280 
(EC958fimX::lacZ) promoter. When grown on LB agar containing X-gal, EC958fimE::lacZ 281 
colonies were pale blue (indicating weak transcription) and EC958fimX::lacZ colonies were 282 
white (indicating no transcription). The two reporter strains were then subjected to Tn5 283 
mutagenesis; in each case 50,000-60,000 transposon mutants were generated and visually 284 
screened based on their blue colour intensity following growth on LB X-gal agar. Individual 285 
colonies that were dark blue (compared to the control strain) were selected and further analyzed 286 
for β-galactosidase activity. Genes identified to contain transposon insertions that altered the β-287 
galactosidase activity of EC958fimE::lacZ or EC958fimX::lacZ are listed in Tables 3 and 4, 288 
respectively. Strikingly, multiple independent mutants containing insertions in the guaB gene 289 
were identified for both EC958fimE::lacZ and EC958fimX::lacZ; thus the remainder of this 290 
study focused on understanding the regulatory role of guaB on fimE and fimX transcription.  291 




Deletion of guaB in EC958 leads to up-regulation of the fimE and fimX recombinase genes but 293 
slower fimS ‘on’ switching 294 
In order to study how guaB regulates fimE and fimX, we constructed defined deletion mutants in 295 
EC958fimE::lacZ and EC958fimX::lacZ to generate the following strains: EC958fimE::lacZ guaB 296 
and EC958fimX::lacZ guaB. Activity from the fimE and fimX promoters was measured by 297 
determining the β-galactosidase activity from control and guaB mutant strains (Fig. 8A, B). 298 
Deletion of guaB resulted in significantly increased promoter activity from both 299 
EC958fimE::lacZ guaB (2-fold, P<0.05, Fig. 8A) and EC958fimX::lacZ guaB (1.5-fold, P<0.05, 300 
Fig. 8B). Furthermore, complementation of the mutant strains by over-expressing guaB in trans 301 
(via plasmid pGuaB) resulted in promoter activity comparable to the parental controls. These 302 
results strongly suggest that the guaB gene product contributes to the regulation of fimE and fimX 303 
in EC958.  304 
 305 
To further assess the effect of guaB on fimS inversion, we generated an EC958guaB mutant and 306 
determined its switching profile using DISCus. Static subculture of EC958 and EC958guaB was 307 
performed over a 5-day period as described in previous sections. DISCus analysis of fimS was 308 
performed on samples at days 1, 3 and 5. Analysis of samples taken at days 3 and 5 revealed a 309 
significantly slower ‘on’ switching profile for EC958guaB compared to EC958 (Fig. 8C). 310 
Furthermore, this slower fimS switching rate was restored to wild-type level following 311 
complementation of EC958guaB with plasmid pGuaB (Fig. 8C). Taken together, this data 312 
strongly supports a role for the guaB gene in fimS inversion.  313 
 314 
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The effect of guaB deletion on fimE and fimX transcription is partially dependent on GTP 315 
homeostasis and mimics (p)ppGpp stress response conditions 316 
Guanosine tetra- and pentaphosphate, also known as (p)ppGpp, is a stress response alarmone that 317 
has been shown to increase type 1 fimbriae expression by up-regulating fimB and to a lesser 318 
extent, fimE transcription in E. coli (36). GuaB catalyzes the rate-limiting step in GMP 319 
biosynthesis and its deletion depletes the intracellular GTP pool (37, 38). Production of large 320 
amounts of (p)ppGpp can also result in a sharp decline in the intracellular GTP level both by 321 
direct GTP consumption and by (p)ppGpp-mediated GuaB inhibition (38, 39). Thus, (p)ppGpp is 322 
involved in regulating intracellular GTP homeostasis (38).  323 
 324 
We hypothesized that the effect of guaB deletion on fimE and fimX transcription in EC958 may 325 
be mediated through (p)ppGpp and tested this using pooled human urine as a growth medium. 326 
We predicted that guaB deletion would induce the stringent response as a result of reduced 327 
cellular GTP and trigger (p)ppGpp production by the action of purine salvage pathways (40) 328 
utilizing guanine and guanosine species present in human urine (41, 42). Elevated levels of 329 
(p)ppGpp, in turn, would cause increased transcription of fimE and fimX. To test this, we first 330 
used a sub-inhibitory concentration of serine hydroxamate (SHX, 0.2 mM) to induce (p)ppGpp 331 
generation within the cell via depletion of serine-charged t-RNA, leading to activation of the 332 
amino acid starvation pathway (43). Stationary phase cultures of EC958fimE::lacZ and 333 
EC958fimX::lacZ grown in the presence or absence of SHX were analyzed for β-galactosidase 334 
activity (Fig. 9). The addition of SHX led to a significant de-repression of the fimE promoter 335 
(Fig. 9A; P<0.05), albeit not to the level seen in EC958fimE::lacZ guaB. No significant change 336 
was observed in fimX promoter activity (Fig. 9B).  337 




Next, we attempted to replenish the depleted intracellular GTP pool in guaB deletion reporter 339 
strains by direct supplementation with GTP. The rationale behind this was that restoring 340 
intracellular GTP levels would rescue the cell from stress, leading to a decline in (p)ppGpp 341 
production and a subsequent decrease in fimE and fimX transcription. Thus, EC958fimE::lacZ 342 
guaB and EC958fimX::lacZ guaB were grown in pooled human urine supplemented with 0.5 mM 343 
GTP. For both strains, the addition of GTP led to a significant decrease in fimE (P<0.01) and 344 
fimX (P<0.05) promoter activities to levels similar to those observed in the parent 345 
EC958fimE::lacZ (Fig. 9C) and EC958fimX::lacZ strains (Fig. 9D). Taken together, these results 346 
suggest that GTP depletion in a guaB mutant background mimics conditions observed during 347 
(p)ppGpp stress and is at least partially responsible for increased transcription of fimE and fimX. 348 
 349 
The guaB gene is required for EC958 persistence in urine and bladder colonization in a mouse 350 
UTI model 351 
In order to assess the contribution of guaB to the virulence of EC958, we tested the ability of the 352 
EC958guaB mutant to survive in the mouse urinary tract using a competitive infection assay. We 353 
employed an EC958lac strain as the wild-type to enable differentiation of both strains on 354 
MacConkey lactose medium; EC958lac colonized the mouse bladder in equivalent numbers to 355 
wild-type EC958 in a mixed competitive infection (Supporting Information Fig. S4A, B). 356 
EC958lac and EC958guaB inocula were prepared by four successive rounds of static subculture 357 
in LB broth (3x48 hours followed by 1x24 hours); under these conditions both strains expressed 358 
similar levels of type 1 fimbriae (Supporting Information Fig. S4C). Female C57BL/6 mice were 359 
co-inoculated with 1:1 ratio of EC958lac and EC958guaB, and the colonization of each strain 360 
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was assessed at 24 hours post infection. In these experiments, EC958guaB was significantly 361 
outcompeted by EC958lac in the bladder (P<0.01) and urine (P<0.05) of infected mice (Fig. 10). 362 
  363 




The emergence and rapid spread of the UPEC ST131 clone has been well documented since 365 
2008 with epidemiological reports from all over the world. Like other UPEC, E. coli ST131 366 
strains utilize type 1 fimbriae for colonization of the urinary tract. However, most ST131 isolates 367 
from the globally predominant clade C sub-lineage possess an ISEc55 insertion element within 368 
the tyrosine-like recombinase fimB gene that is associated with reduced type 1 fimbriae 369 
expression (8, 28). Here, we define the molecular basis of fimS inversion in this clinically-370 
relevant fluoroquinolone-resistant group of E. coli ST131 strains.  371 
 372 
The high prevalence of the fimB::ISEc55 insertion in ST131 strains from clade C led us to assess 373 
the impact of this insertion on type 1 fimbriae expression. We have previously reported a delayed 374 
‘on’ switching phenotype of type 1 fimbriae expression in a subset of the strains used in the 375 
current study (8). We therefore compared the type 1 fimbriae expression profile of a large 376 
collection of ST131 strains that possessed an intact or disrupted fimB gene over multiple rounds 377 
of static subculture. Overall, in accordance with previous observations (8), most ST131 strains 378 
containing the fimB::ISEc55 insertion were able to express type 1 fimbriae, but exhibited a 379 
slower ‘off’ to ‘on’ switching profile during static growth. Interestingly, in the present analysis, 380 
six strains were unable to express type 1 fimbriae after prolonged subculture, suggesting they 381 
lack the capacity to make functional type 1 fimbriae. Two of these strains had large deletions in 382 
the fim operon and transformation of the remaining four strains with a plasmid containing fimB 383 
induced type 1 fimbriae expression in only one strain. All three remaining strains harboured the 384 
fimX recombinase gene previously reported to switch fimS ‘on’ (24), indicating that they may 385 
contain other mutations that disrupt this phenotype.  386 




The presence of the ISEc55 insertion element in fimB was associated with increased transcription 388 
of the downstream fimE gene in the clade C representative EC958 strain and four other clade C 389 
ST131 strains. Mapping of the fimE promoter in these strains revealed that ISEc55 did not 390 
contain an independent promoter driving fimE transcription. However, we did observe that 391 
deletion of H-NS, a global transcriptional regulator and a known repressor of fimE (35), did not 392 
have a major effect on fimE transcription in EC958. H-NS is known to bind preferentially to 393 
intrinsically-curved DNA and AT-rich sequences, usually found in promoter regions, to exert 394 
regulatory effects on its many target genes (44, 45). Our observations indicate an in trans effect 395 
of ISEc55 that could alter the local DNA structure and inhibit H-NS binding. Indeed, analogous 396 
alterations in the transcription of genes adjacent to other insertion elements have been 397 
documented in E. coli (46-48). 398 
 399 
Analysis of E. coli ST131 genomes has revealed that the fim region is associated with 400 
recombination (7, 28). Here, we provide a comprehensive analysis of type 1 fimbriae regulation 401 
in fluoroquinolone-resistant clade C ST131 strains that contain the fimB::ISEc55 insertion. The 402 
expression of type 1 fimbriae by the majority of ST131 strains containing the fimB::ISEc55 403 
insertion suggested that they possess an alternative recombinase/s capable of fimS inversion. 404 
Using a combined mutagenesis and complementation strategy, we showed that both FimE and 405 
FimX could mediate fimS inversion in EC958, with FimE demonstrating the greatest fimS 406 
inversion activity under the static growth conditions employed in this study. We did not observe 407 
any significant difference in fimX transcript levels in ST131 strains with an intact fimB and those 408 
with the fimB::ISEc55 insertion. We also developed DISCus, a novel read-mapping approach 409 
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based on Illumina sequencing, to quantitatively determine the percentage of fimS ‘on’ or ‘off’ 410 
populations. Our data suggest that fimE plays a more important role than fimX in regulating the 411 
orientation of fimS during in vitro culture. This is in agreement with a previous report that 412 
detected relatively low levels of FimX activity in vitro, but observed rapid expression of type 1 413 
fimbriae upon experimental infection in strains with FimX as the only active recombinase (25). 414 
The role of FimX in the inversion of fimS in EC958 during in vivo infection remains to be 415 
elucidated. In this respect, DISCus could be used to monitor fimS orientation in such populations. 416 
We also note that DISCus could be applied more broadly to analyze DNA invertible elements in 417 
other bacteria. 418 
 419 
To identify potential regulators of the fimE and fimX genes in EC958, we employed random 420 
transposon mutagenesis of the fimE and fimX reporter strains and identified several genes that 421 
when mutated caused increased activity of the fimE and fimX promoters. The guaB gene, which 422 
encodes an enzyme that catalyzes the first rate limiting step in de novo GTP/GDP biosynthesis 423 
and is responsible for maintaining GTP homeostasis (49), was identified in screens of both 424 
reporter strains and was the focus of subsequent experimental analysis (see below). Mutation of 425 
several other genes was also linked with increased fimE promoter activity (yubO, pdxH, lrhA, 426 
dprA) or increased fimX promoter activity (betA, yjjA). The LysR family transcriptional regulator 427 
lrhA has previously been shown to repress both fimB and fimE (50), and our identification of 428 
lrhA in this study as a repressor of fimE is consistent with these results. The yubO gene is located 429 
on a 135.6 kb IncF plasmid in EC958 and encodes a protein of unknown function (51). Three 430 
independent Tn5 mutants were identified in yubO, however specific mutagenesis of yubO failed 431 
to reproduce a significant increase in fimE transcription (data not shown). Thus, a definite role 432 
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for yubO in type 1 fimbriae regulation remains to be demonstrated. The dprA gene encodes a 433 
putative DNA processing protein implicated in natural bacterial transformation (52) and has been 434 
previously reported to be expressed in vivo during UTI (53). However, the molecular mechanism 435 
by which dprA might affect fimE transcription, as well as the role of pdxH (encodes an enzyme 436 
required for vitamin B6 biosynthesis (54)), betA (encodes a choline dehydrogenase (55)) and yjjA 437 
(encodes a putative metal chaperone) in type 1 fimbriae expression, remains to be determined.   438 
 439 
We focused our molecular investigation on the role of the guaB gene in fimE and fimX 440 
regulation. While there is no direct link between guaB and expression of type 1 fimbriae in the 441 
literature, guaB has been shown to be upregulated in women with UTI (53) and is important for 442 
UPEC fitness in an experimental model of systemic infection (56). In other studies, the (p)ppGpp 443 
alarmone, synthesized from GTP, has been shown to increase type 1 fimbriae expression in 444 
E. coli (36). Strains lacking any (p)ppGpp exhibit reduced transcription from the fimB and fimE 445 
promoters, although the effect on the latter gene is approximately half of that reported for fimB 446 
(36). Under conditions of nutritional stress, (p)ppGpp controls global metabolic changes within 447 
the cell (57-59) via direct interaction with RNA polymerase (60, 61) and activation of stress-448 
associated sigma factors (57). Synthesis of (p)ppGpp results in a reduction of the intracellular 449 
GTP pool (62-64). Recently, it has been reported that (p)ppGpp directly inhibits various GTP 450 
biosynthesis enzymes, thus further lowering the level of cellular GTP (38). We hypothesized that 451 
deletion of guaB would produce a GTP deficient state mimicking that observed during the 452 
activation of the stringent response pathway, and that this in turn would increase fimE and fimX 453 
promoter activity. Chemical induction of this pathway in EC958 increased fimE promoter 454 
activity and the addition of GTP to the culture media of guaB mutant strains significantly 455 
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reduced both fimE and fimX promoter activity. Taken together, these data support the hypothesis 456 
that the cellular GTP concentration influences type 1 fimbriae expression by controlling the 457 
transcription of fimE and fimX. We suggest that this effect is partly mediated by the action of the 458 
(p)ppGpp alarmone on fimE promoter activity in strains that lack a functional copy of the fimB 459 
gene. Indeed, DISCus analysis of EC958guaB revealed an overall slower fimS ‘on’ switching 460 
phenotype compared to the wild-type EC958, possibly due to the strong natural bias for FimE to 461 
mediate ‘on’ to ‘off’ switching (14, 65). These findings are also consistent with our mouse 462 
colonization data, which showed that an EC958guaB mutant was significantly outcompeted by 463 
wild-type EC958 with respect to bladder colonization and persistence in urine. 464 
 465 
In conclusion, this work has identified and characterized several novel molecular mechanisms 466 
associated with the regulation of type 1 fimbriae in E. coli ST131 strains that harbour an ISEc55 467 
insertion in the fimB recombinase gene. Our data demonstrate that type 1 fimbriae regulation in 468 
these strains is different to that described for non-ST131 UPEC, highlighting the importance of 469 
understanding the control of this essential virulence factor in the context of a clinically dominant 470 
MDR resistant clone. Overall, the impact of this mutation on the fitness and global dissemination 471 
of ST131 remains to be determined. However, given that the only non-ST131 strain shown to 472 
harbour the fimB::ISEc55 insertion to date is the probiotic Nissle 1917 strain (8), it is tempting to 473 
speculate that such modulation of type 1 fimbriae expression may be associated with enhanced 474 
colonization of the gut. 475 
  476 
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Experimental Procedures 477 
Ethics statement  478 
Approval for mouse infection studies was obtained from the University of Queensland Animal 479 
Ethics Committee (SCMB/471/09/NHMRC (NF)). Experiments were carried out in strict 480 
accordance with the recommendations in the Animal Care and Protection Act (Queensland, 481 
2002) and the Australian Code of Practice for the Care and Use of Animals for Scientific 482 
Purposes (8th edition, 2013). Approval for the collection of human urine was obtained from the 483 
University of Queensland Institutional Human Research Ethics Committee (2015000347) and the 484 
Griffith University Human Ethics Research Committee (MSC/06/08/HREC). Participation was 485 
voluntary and all individuals provided informed consent prior to participation in the study. 486 
 487 
Bacterial strains and growth conditions  488 
The E. coli strains and plasmids used in this study are listed in Table S1 in the Supporting 489 
Information. E. coli EC958 is a completely sequenced fluoroquinolone-resistant Clade C ST131 490 
strain originally isolated in the United Kingdom in 2005 (7, 8, 29). Other E. coli ST131 strains 491 
were isolated from urine samples collected at hospitals in Manchester and Preston, Northwest 492 
England (n=54) and Brisbane, Australia (n=37). Most of the isolates (n=71) used in the present 493 
study have been described previously (7, 8, 29, 66-68). The additional 21 strains were collected 494 
from Brisbane, Australia as part of routine methods for UTI diagnosis. Strains were routinely 495 
cultured at 37°C on solid or in liquid lysogeny broth (LB) unless otherwise specified. Culture 496 
media was supplemented with appropriate antibiotics as required: gentamicin (Gent, 20 µg ml-1), 497 
chloramphenicol (Cm, 30 µg ml-1). Human urine, when used as culture media, was pooled from 498 
at least three healthy donors with no recent history of antibiotic use. 499 




DNA manipulations and genetic techniques 501 
Chromosomal DNA purification, PCR and DNA sequencing was performed as previously 502 
described (69). PCR screening for the presence of fimH (70) and the insertion element within 503 
fimB was performed as previously reported (8). The sequence type of UTI isolates used in this 504 
study was determined by multilocus sequence typing as previously described (4, 66, 67). DNA 505 
extraction for Illumina sequencing was performed using the Ultraclean® Microbial DNA 506 
Isolation Kit (MO BIO Laboratories). Restriction enzymes were purchased from New England 507 
Biolabs (Genesearch, Australia). All mutants, tagged strains and plasmid constructs were 508 
confirmed by PCR followed by Sanger sequencing performed at the Australian Equine Genetics 509 
Research Centre (Queensland, Australia). Illumina sequencing was performed at the Australian 510 
Genome Research Facility (Melbourne, Australia). 511 
 512 
Construction of plasmids  513 
The plasmids used for in trans complementation were created by PCR amplification of the 514 
respective gene from EC958 (fimB was amplified from CFT073) using primers listed in 515 
Supporting Information Table S1. Relevant PCR products were digested with SacI-HindIII and 516 
ligated into SacI-HindIII-digested pSU2718 (71). The cloned genes were under the control of a 517 
lac promoter; cloned genes were induced by the addition of 1 mM IPTG (Sigma Aldrich) to the 518 
culture medium. 519 
 520 
Construction of deletion mutants and complemented strains  521 
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EC958 mutants were constructed using λ-Red mediated homologous recombination as 522 
previously described (8) using primers listed in Table S1. A three-step PCR procedure was 523 
employed for the generation of products with 500 bp homology regions used in recombination 524 
(72). Plasmid pCP20 (73) was modified by the introduction of a gentamicin resistance cassette at 525 
the NcoI site to yield pCP20-Gent. For complementation of mutants, removal of the FRT-site-526 
flanked chloramphenicol cassette was mediated by the Flp recombinase expressed by pCP20-527 
Gent. Mutant strains were then complemented by introduction of the respective genes cloned into 528 
the low-copy number pSU2718 plasmid. All lacZ reporter-tagged transcriptional fusions were 529 
generated in an mKate2-tagged EC958lac background using PCR products with a lacZ-Cm 530 
cassette flanked by 500 bp homology regions specific to fimE or fimX. 531 
  532 
Type 1 fimbriae expression profile  533 
A type 1 fimbriae expression profile was established for all 91 E. coli ST131 strains examined in 534 
this study. Strains were grown overnight on LB agar, and single colonies were picked and used 535 
to inoculate a 5 ml LB for overnight aerobic (shaking) growth. A volume of 1 µl of each 536 
overnight culture was inoculated into a new tube containing 5 ml LB and cultured for 24 hours 537 
under static conditions. Strains were sub-cultured from the air-liquid interface in a similar 538 
manner for further growth. Type 1 fimbriae expression was determined at each stage of 539 
subculture using a yeast cell agglutination assay as previously described (8). Type 1 fimbriae 540 
expression of EC958 wild-type and mutant derivatives was monitored similarly. The orientation 541 
of fimS was evaluated from single colonies by PCR as previously described with primers 2848, 542 
2859 and 2850 listed in Table S1 (24). Cells from colonies with fimS in the ‘off’ orientation were 543 
used to inoculate 5 ml LB broth and cultured for 24 hours under static conditions; a volume of 10 544 
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µl was taken from the air-liquid interface and used to generate a new subculture every 24 hours 545 
over a 5-day period.  For each subculture, type 1 fimbriae expression was monitored by yeast cell 546 
agglutination and western blot analysis of whole cell lysates using a FimA-specific antibody. A 547 
volume of 1 ml was also collected from the air-liquid interface at each 24-hour time point; cells 548 
were pelleted by centrifugation, genomic DNA was extracted and sequenced using Illumina 549 
technology for DISCus analysis. 550 
  551 
RNA isolation, cDNA synthesis and quantitative RT-PCR (qRT-PCR) analysis 552 
 RNA was extracted from bacteria grown aerobically at 37°C in M9 minimal medium 553 
supplemented with 0.2% glucose (w/v) (74). Mid-log phase cultures were standardized to OD600 554 
= 0.6 prior to RNA extraction using the RNeasy Protect Bacteria Mini Kit (Qiagen) following the 555 
manufacturer’s guidelines. RNA was treated with RNase-free DNase I to remove contaminating 556 
DNA and re-puriﬁed using Qiagen RNeasy columns. RNA samples were quantiﬁed 557 
spectrophotometrically at 260nm. cDNA synthesis was performed with 1 µg total RNA and 558 
random hexamer primers using the SuperScript®III First Strand Synthesis System (Life 559 
Technologies) according to the manufacturer’s instructions. All cDNA samples were diluted 10-560 
fold prior to semi-quantitative real time PCR (qRT-PCR) analysis. qRT-PCR reactions were 561 
performed using SYBR® Green Master Mix (Applied Biosystems) and 500 nM gene specific 562 
primers for fimE, fimX and gapA (Supporting Information Table S1) on a ViiA™ 7 instrument 563 
(Life technologies) with the following cycling parameters: initial denaturation at 95°C for 10 min 564 
followed by 40 cycles of denaturation at 95°C for 15 s, annealing at 60°C for 15 s and elongation 565 
at 72°C for 30 s. Each reaction was performed in quadruplicate. Amplicon specificity was 566 
confirmed via gel and melting curve analysis. The ViiA™ 7 software determined the threshold 567 
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cycle (Ct) for each reaction. The expression of fimE and fimX was normalized to gapA expression 568 
for each sample and the 2-∆∆Ct method (75) was employed to calculate the difference in 569 
expression of the fim recombinase genes between strains with an intact fimB and those with a 570 
fimB::ISEc55 insertion. 571 
 572 
Rapid amplification of cDNA ends (5' RACE)  573 
The transcription start site (TSS) of fimE was mapped using the 5' RACE system (Life 574 
Technologies) according to manufacturer’s guidelines. Briefly, total RNA was isolated as 575 
described above and first strand cDNA synthesis was performed using SuperScript™ II and a 576 
gene-specific primer (Supporting Information Table S1, primer 4342). The resulting cDNA was 577 
purified and a homopolymeric tail was added to its 3’-end using TdT and dCTP. The cDNA was 578 
then amplified by PCR using an anchor primer (supplied) and a gene-specific primer (Supporting 579 
Information Table S1, primer 4343) followed by another round of nested PCR (primer 4344). 580 
The purified PCR product was then sequenced to determine the TSS. 581 
 582 
Sequence analysis of fimE 583 
Nucleotide sequences of ST131 fimE promoter and coding regions (1074 bp) were obtained from 584 
previously published genomes of strains used in this study (n=26) (7). The corresponding 585 
sequences from two reference non-ST131 UPEC strains, UTI89 (GI: 91209055) and CFT073 586 
(GI: 26111730) and the E. coli K-12 strain MG1655 (GI: 556503834) were included for 587 
comparison. Multiple sequence alignment was performed using Clustal X v2.0 (76) to construct 588 
a neighbour-joining phylogenetic tree which was then visualised with FigTree v1.4.2 589 
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[http://tree.bio.ed.ac.uk/software/figtree/]. Amino acid sequences of the FimE protein (198 AA) 590 
were also aligned using Clustal X2. 591 
 592 
Quantification of the fimS promoter switching frequency using DISCus  593 
To accurately measure invertible DNA switching, a read mapping approach was developed to 594 
determine the frequency of Illumina sequence reads that mapped uniquely to the ‘on’ or ‘off’ 595 
orientation of the fimS invertible switch. To determine the ratio of ‘off’ to ‘on’ mapped reads, a 596 
pseudo-reference containing both fimS orientations and 1 kbp of flanking sequence was 597 
constructed using the relevant sequence from EC958 (GI:641682562). An analogous approach 598 
was taken to construct a pseudo-reference for the hyxR promoter region. Illumina 100 bp paired-599 
end reads from ST131 strains were then mapped to the pseudo-reference sequences using 600 
Burrows-Wheeler Aligner  (77), and inter-converted to SAM (Sequence Alignment/Map) and 601 
BAM (Binary Alignment/Map) files using SAMtools where necessary (78). To ascertain the 602 
number of reads overlapping the unique bordering regions of the ‘off’ and ‘on’ orientations, and 603 
thereby their relative switching frequencies, Bedmaps was used to count reads overlapping 10 bp 604 
pseudo-exons, which were created at both edges of the ‘off’ and ‘on’ orientations (79). The 605 
number of paired-reads, which traversed these bordering regions, was also counted. This was 606 
accomplished by assigning six regions in the pseudo-reference, corresponding to ‘left flank’, 607 
‘right flank’ or ‘switch region’ for both the ‘off’ and ‘on’ orientation. Paired end read locations 608 
were determined from the BAM file and counted if they were found to traverse from a ‘switch 609 
region’ to either ‘flank’ for the ‘off’ or ‘on’ orientation respectively. Reads were not counted if 610 
they were unpaired or traversed from an ‘on’ region to an ‘off’ region. Final read counts were 611 
normalised as a percentage of total input reads to allow comparison between independent 612 
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samples. Python and Bash scripts for generating pseudo-reference sequences and automating 613 
DISCus, respectively, are available in a public repository at 614 
https://github.com/LeahRoberts/DISCus.  615 
 616 
Transposon mutagenesis analysis 617 
A mini Tn5-Cm transposon containing a chloramphenicol (Cm) cassette flanked by Tn5 mosaic 618 
ends was PCR amplified from NotI-digested pKD3 plasmid with primers 2279 and 2280 619 
(Supporting Information Table S1). The amplicon was phosphorylated using T4 polynucleotide 620 
kinase (New England Biolabs) and mixed with EZ-Tn5™ transposase (Epicenter 621 
Biotechnologies) to create transposomes according to the manufacturer’s guidelines. 622 
Electrocompetent cells of EC958 fimE and fimX promoter-lacZ transcriptional fusion strains 623 
were prepared as previously described (80). Cells were electroporated with transposomes and 624 
after a 2 h recovery period in SOC, were spread on LB plates supplemented with Cm and 5-625 
bromo-4-chloro-3-indolyl-D-galactoside (X-Gal). Approximately 50,000 to 60,000 Cm resistant 626 
mutants were obtained for each strain. Mutant colonies were visually screened for increased blue 627 
color intensity on X-Gal plates using the parental strains as controls. Selected mutants were 628 
further screened for lacZ expression by measurement of β-galactosidase activity. The transposon 629 
insertion site of mutants with altered β-galactosidase activity was determined using an arbitrary 630 
PCR (using primers 2209 and 1799; Supporting Information Table S1) followed by a nested PCR 631 
(using primers 2240 and 1801) and sequencing of the final amplicon. Mutation of the guaB gene 632 
in EC958fimE::lacZ-cm and EC958fimE::lacZ-cm was performed using λ-Red homologous 633 
recombination as described above.  634 
 635 
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β-Galactosidase assays  636 
β-Galactosidase assays were performed essentially as previously described (81). Briefly, strains 637 
carrying fimE and fimX promoter-lacZ transcriptional fusions were grown overnight in pooled 638 
human urine alone or supplemented with 0.2 mM serine hydroxamate (SHX) or 0.5 mM GTP as 639 
indicated. Cultures were diluted in Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 50 mM β-640 
mercaptoethanol, 10 mM KCl, 1 mM MgSO4 at pH 7.0) followed by the addition of 0.004% SDS 641 
(w/v) and chloroform to permeabilize the cells. The samples were incubated at 28°C, and 642 
reactions were initiated by the addition of ortho-Nitrophenyl-β-D-galactopyranoside (ONPG). 643 
The reactions were stopped with the addition of Na2CO3 (300 mM). The enzymatic activity 644 
(expressed in Miller units) was assayed in quadruplicate for each strain by measuring the 645 
absorbance at 420 nm. 646 
  647 
Mouse model of UTI 648 
The C57BL/6 mouse model of ascending UTI was employed as previously described (69). All 649 
strains used in this experiment were enriched for type 1 fimbriae expression by three successive 650 
rounds of static growth in LB for 48 hours followed by one round of static growth for 24 hours 651 
for inoculum preparation. All strains were positive for type 1 fimbriae expression as determined 652 
by yeast cell agglutination and western blot analysis. Infections were performed as competitive 653 
assays; the inoculum contained 1:1 strain mixture of EC958 WT (lac- strain) and EC958guaB. 654 
Bacteria (5x108 CFU in 30 µl PBS) were injected transurethrally into female C57BL/6 mice (8-655 
10 weeks). Urine was collected from mice 24 h post challenge, after which they were euthanized 656 
by cervical dislocation. Bacterial loads in urine and bladder were enumerated as colony forming 657 
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units (CFU) counts. The two strains were differentiated by colony colour on MacConkey plates: 658 
white (lac- WT) or pink (EC958guaB). 659 
  660 
Statistical Analysis  661 
All statistical analyses were performed using the GraphPad Prism 6 software package. 662 
Significant associations between fimB status and type 1 fimbriae expression were investigated 663 
with the χ2 test. Statistical significance of fold-changes in fimE transcript levels between ST131 664 
strains was determined using a two-tailed Mann Whitney test. The Wilcoxon matched pairs 665 
signed-rank test and repeated-measures one-way ANOVA with Dunnett’s multiple comparisons 666 
test were used to analyse results from β-galactosidase assays. A Pearson’s χ2 test with Yates’ 667 
continuity correction was used to compare raw read counts generated by DISCus using RStudio 668 
(v0.98.501). The significance level was adjusted to 0.0167 (alpha = 0.05, Bonferroni adjusted for 669 
three pairwise comparisons). Data from mouse UTI experiments was analyzed using a two-tailed 670 
Wilcoxon matched pairs signed-rank test. In all instances, statistical significance was considered 671 
at P<0.05. 672 
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Tables  966 
Table 1. Type 1 fimbriae expression profile of E. coli ST131 strains 967 
 
Number of yeast agglutination positive ST131 strains 
following overnight growth in LB broth at 37°C (%) 
fimB Status 
Shaking 
culture Static subculture 
 Day 1 Day 1 Day 2 Day 3 
fimB::ISEc55 (n=57) 8 (14) 27 (47.4) 34 (59.6) 52 (91.2) 
Intact fimB (n=34) 24 (70.6)*** 27 (79.4)* 27 (79.4) 29 (85.3) 
*P<0.01, ***P<0.0001; χ2 test. 968 
 969 
  970 
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Table 2. Effect of FimB over-expression in type 1 fimbriae negative strains 971 





S1 fimB::ISEc55 Wild-type OFF - 
  + pFimB ON - 
S18 fimB::ISEc55 Wild-type OFF - 
  + pFimB ON + 
S27 Intact Wild-type OFF - 
  + pFimB OFF - 
S61 fimB::ISEc55 Wild-type OFF - 
  + pFimB ON - 
*Yeast agglutination negative (-), positive (+) 972 
 973 
  974 
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Table 3. Mutated genes associated with increased fimE promoter activity 975 
EC958 locus 
tag 





































EC958_2624 lrhA LysR homologue 
A 
1 2348±365 5.52±1.35 
EC958_3829 dprA putative DNA 
processing 
protein 
1 1358±59 3.20±0.62 
SD, Standard deviation. 976 
aValues represent data from each independently isolated Tn5 mutant. 977 
bβ-gal activity of control strain EC958fimE::lacZ = 425±80. 978 
 979 
  980 
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Table 4.  Mutated genes associated with increased fimX promoter activity 981 
SD, Standard deviation. 982 
aβ-gal activity of control strain EC958fimX::lacZ = 62±4. 983 
  984 
EC958 locus 
tag 












EC958_2815 guaB inosine 5' 
monophosphate 
dehydrogenase 
1 94±7 1.52±0.15 
EC958_0463 betA choline 
dehydrogenase 
1 108±9 1.74±0.18 
EC958_0090 yjjA putative metal 
chaperone 
1 94±7 1.52±0.15 
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Table 5. Strains and plasmids used in this study 985 
Straina Description Reference 
CFT073 Wild-type UPEC isolate (82) 
536 Wild-type UPEC isolate (83) 
UTI89 Wild-type UPEC isolate (84) 
IHE3034 Wild-type UPEC isolate (85) 
EC958 Wild-type UPEC isolate; E. coli ST131 ESBL (8) 
S1 pFimB E. coli ST131 strain S1 pFimB, ESBL, Cmr This study 
S18 pFimB E. coli ST131 strain S18 pFimB, ESBL, Cmr This study 
S27 pFimB E. coli ST131 strain S27 pFimB, ESBL, Cmr This study 
S61 pFimB E. coli ST131 strain S61 pFimB, ESBL, Cmr This study 
CFT973hns CFT073hns::kan, Kanr (86) 
536hns 536hns::kan, Kanr This study 
UTI89hns UTI89hns::kan, Kanr This study 
IHE3034hns IHE3034hns::kan, Kanr This study 
EC958hns EC958hns::cm, ESBL, Cmr (87) 
MS3198 CFT073lacIZ upaH:lacZ-zeo (88) 
EC958 pKOBEG-
Gent EC958 pKOBEG-Gent, ESBL Gent
r (8) 
EC958fimE EC958fimE::cm, ESBL Cmr This study 
EC958fimX EC958fimX::cm, ESBL Cmr This study 
EC958fimE fimX EC958fimE fimX::cm, ESBL Cmr This study 
EC958fimE fimX 
pSU2718 EC958fimE fimX, ESBL Cm
r This study 
EC958fimE fimX  
pFimE EC958fimE fimX pFimE, ESBL Cm
r This study 
EC958fimE fimX  
pFimX EC958fimE fimX pFimX, ESBL Cm
r This study 
EC958lac::mKate2 EC958lac::mKate2::cm, ESBL Cmr (87) 
EC958fimE::lacZ-cm EC958lac::mKate2 fimE::lacZ-cm, ESBL Cmr This study 
EC958fimX::lacZ-cm EC958lac::mKate2 fimX::lacZ-cm, ESBL Cmr This study 
EC958fimE::lacZ 
guaB 
EC958lac::mKate2 fimE::lacZ guaB::cm, ESBL 
Cmr This study 





EC958lac::mKate2 fimX::lacZ guaB::cm, ESBL 
Cmr This study 
EC958fimE::lacZ 
guaB (pGuaB) 
EC958lac::mKate2 fimE::lacZ guaB::cm pGuaB, 
ESBL Cmr This study 
EC958fimX::lacZ 
guaB (pGuaB) 
EC958lac::mKate2 fimX::lacZ guaB::Cm pGuaB, 




pKOBEG-Gent λ-Red plasmid, replicates at 37°C, araC arabinose inducible promoter, Gentr (8, 89) 
pCP20-Gent Replicates at 30°C, encodes Flp recombinase, Gentr This study, (73) 
pSU2718 Cloning vector, Plac promoter, replicates at 37°C, Cmr (71) 
pFimB pSU2718 fimB; fimB coding sequence from CFT073, Cmr This study 
pFimE pSU2718 fimE; fimE coding sequence from EC958, Cmr This study 
pFimX pSU2718 fimX; fimX coding sequence from EC958, Cmr This study 
pGuaB pSU2718 guaB; guaB coding sequence from EC958, Cmr This study 
aIn addition to the strains listed above, our E. coli ST131 strain collection comprised of 54 strains 986 
from the United Kingdom (S1-S54, including EC958; (7, 8, 29, 66, 68) and 37 strains from 987 
Australia (S55-S91; (7, 8, 67); Cmr-chloramphenicol, Gentr-gentamicin resistant, Kanr-988 
kanamycin resistant. 989 
 990 
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Figure Legends 992 
Fig. 1. Schematic representation of the type 1 fimbrial operon. The 1895bp fimB::ISEc55 993 
insertion sequence element is depicted in its genomic context. CFT073, reference UPEC strain; 994 
EC958, representative E. coli ST131 clade C strain; adapted from Totsika et al.(8). 995 
 996 
Fig. 2. Quantification of fimE and fimX transcription in ST131 strains by qRT-PCR.  997 
The level of fimE (A) and fimX (B) transcription relative to housekeeping gene gapA was 998 
determined by qRT-PCR in mid-log phase ST131 strains with the fimB::ISEc55 insertion (n=5, 999 
including EC958) and compared to those with an intact fimB (n=4) to determine fold-difference 1000 
in gene expression between the two groups using the 2-∆∆Ct method. Bars represent group means 1001 
± standard deviation (SD). Asterisk indicates a statistically significant difference between the two 1002 
groups (P<0.05) as determined by the two-tailed Mann Whitney test. 1003 
 1004 
Fig. 3. Analysis of fimE promoter sequence.  1005 
The transcription start site (TSS) of fimE was mapped by 5’RACE in EC958 and five other 1006 
E. coli ST131 strains (S4, S54, S69, S88 and S90). Shown here is the consensus nucleotide 1007 
sequence. The -35 and -10 promoter elements are underlined and the TSS mapped to a G residue 1008 
164 bases upstream of the GTG start codon (indicated by the curved arrow).  1009 
 1010 
Fig. 4. Contribution of FimE and FimX to fimS inversion and type 1 fimbriae expression in 1011 
EC958.  1012 
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Western blots demonstrating expression of the FimA major subunit protein of type 1 fimbriae 1013 
using α-FimA antibody and yeast cell agglutination assays to monitor type 1 fimbriae expression 1014 
(- negative, + positive fimbriae expression) in static cultures.  1015 
A. Type 1 fimbriae expression was measured in EC958 (wild-type), EC958fimE, EC958fimX, 1016 
and EC958fimE fimX over 5 days of static subculture.  1017 
B. Type 1 fimbriae expression in EC958fimE fimX strains over 3 days of static subculture. 1018 
EC958fimE fimX (pSU2718) was used as an empty vector control. Over-expression of FimE 1019 
(pFimE) and FimX (pFimX) was induced by the addition of 1mM IPTG to the culture media. 1020 
 1021 
Fig. 5. Quantification of fimS switch orientation bias in EC958 wild-type, mutants and 1022 
complemented strains using DISCus.  1023 
A. fimS orientation in EC958, EC958fimE, EC958fimX and EC958fimE fimX over 5 days of 1024 
static subculture quantified using DISCus. Samples from the air-liquid interface of each culture 1025 
were taken on each day and used for genomic DNA extraction and Illumina sequencing. Bars 1026 
represent fimS percentage ‘on’ population within each culture.  1027 
B. DISCus analysis of fimS orientation following in trans complementation with FimE (pFimE) 1028 
or FimX (pFimE) in the EC958fimE fimX double mutant over 3 days of static subculture.  1029 
 1030 
Fig. 6. Quantification of fimX switch orientation bias in EC958 wild-type, mutants and 1031 
complemented strains using DISCus. 1032 
A. DISCus analysis of fimX switch orientation in EC958, EC958fimE and EC958fimX strains 1033 
over 5 days of static subculture. Bars represent percentage fimX switch ‘on’ reads within each 1034 
culture population.  1035 
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B. DISCus analysis of fimX switch orientation in EC958fimE fimX and in EC958fimE fimX 1036 
following in trans complementation with FimE (pFimE) or FimX (pFimE) over 3 days of static 1037 
subculture. 1038 
 1039 
Fig. 7. Effect of hns deletion on fimE transcript level in different UPEC strains.  1040 
A. Fold-change in fimE transcription in EC958hns compared to wild-type EC958 as determined 1041 
by qRT-PCR.  1042 
B-D. Fold-change in fimE transcription in non-ST131 wild-type UPEC strains and their 1043 
corresponding hns deletion mutants, namely UTI89 (B), 536 (C) and IHE3034 (D) as determined 1044 
by qRT-PCR. Vertical bars represent means±SD of three independent replicates. 1045 
 1046 
Fig. 8. Effect of guaB deletion on fimE/fimX promoter activity and fimS switching in EC958.  1047 
A-B. β-galactosidase activity of EC958 fimE (A) and fimX (B) promoter-lacZ reporter strains 1048 
following overnight aerated growth in pooled human urine. All guaB mutant strains and 1049 
complemented derivatives were constructed in their respective promoter-lacZ reporter 1050 
backgrounds. Bars represent means ± SD of at least three independent biological experiments. 1051 
Asterisk indicates a statistically significant difference (P<0.05) as determined by repeated-1052 
measures one-way ANOVA with Dunnett’s multiple comparisons test.  1053 
C. DISCus analysis of the effect of guaB deletion on fimS switching. EC958  1054 
(wild-type), EC958guaB and EC958guaB(pGuaB) were grown statically in LB (37oC) over a 1055 
period of 5 days. Over-expression of GuaB in EC958guaB(pGuaB) was induced by the addition 1056 
of 1mM IPTG. Genomic DNA was extracted after static subculture on days 1, 3 and 5, and 1057 
Illumina sequencing data was analyzed by DISCus. Bars represent percentage ‘on’ reads of fimS 1058 
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in each culture population. Asterisks indicate a statistically significant difference (* P = 0.01-1059 
0.001; *** P < 0.0001) as determined by a Pearson’s χ2 test with Yates’ continuity correction. 1060 
 1061 
Fig. 9. Regulation of fimE and fimX promoter activity by (p)ppGpp.  1062 
A-B. Effect of serine hydroxamate (SHX, 0.2 mM) induced amino acid starvation on the 1063 
promoter activity of fimE (A) and fimX (B) in EC958fimE:lacZ and EC958fimX:lacZ strains, 1064 
respectively. All guaB mutant strains and complemented derivatives were constructed in their 1065 
respective promoter-lacZ reporter backgrounds. Strains were incubated overnight under static 1066 
conditions in pooled human urine and promoter activity was determined by the β-galactosidase 1067 
assay. Bars represent means ± SD of three independent biological experiments with four 1068 
technical replicates. Asterisk indicates a statistically significant difference (P<0.05) as 1069 
determined by the Wilcoxon matched pairs signed-rank test.  1070 
C-D. Effect of GTP (0.5 mM) on the promoter activity of fimE (C) and fimX (D) in 1071 
EC958fimE::lacZ guaB and EC958fimX::lacZ guaB strains, respectively. Asterisks indicate 1072 
statistically significant differences (**P<0.01, *P<0.05) in guaB reporter strains upon addition of 1073 
GTP, as determined by a repeated-measures one-way ANOVA with Dunnett’s multiple 1074 
comparisons test. 1075 
 1076 
 1077 
Fig. 10. Mouse urinary tract colonization by EC958 WT and EC958guaB. Female C57B/L6 mice 1078 
were transurethrally inoculated with a 1:1 mixture of type 1 fimbriae enriched EC958 WT and 1079 
EC958guaB strains in a competitive infection assay. Each marker represents total colony 1080 
forming units (CFU) recovered from each mouse per 1 ml of urine or per 0.1 g of bladder tissue 1081 
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(as labelled) on selective medium. Lines connect data points for the same mouse and horizontal 1082 
bars represent median values. Asterisk indicates statistically significant difference between the 1083 
strains for persistence in urine (P<0.05) as well as bladder colonization (P<0.01) as determined 1084 
by the Wilcoxon matched pairs signed-rank test. 1085 
 1086 





Fig. 1. Schematic representation of the type 1 fimbrial operon. The 1895bp fimB::ISEc55 insertion sequence 
element is depicted in its genomic context. CFT073, reference UPEC strain; EC958, representative E. coli 
ST131 clade C strain; adapted from Totsika et al.(8).  
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Fig. 2. Quantification of fimE and fimX transcription in ST131 strains by qRT-PCR.  
The level of fimE (A) and fimX (B) transcription relative to housekeeping gene gapA was determined by qRT-
PCR in mid-log phase ST131 strains with the fimB::ISEc55 insertion (n=5, including EC958) and compared 
to those with an intact fimB (n=4) to determine fold-difference in gene expression between the two groups 
using the 2-∆∆Ct method. Bars represent group means ± standard deviation (SD). Asterisk indicates a 
statistically significant difference between the two groups (P<0.05) as determined by the two-tailed Mann 
Whitney test.  
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Fig. 3. Analysis of fimE promoter sequence. The transcription start site (TSS) of fimE was mapped by 5’RACE 
in EC958 and five other E. coli ST131 strains (S4, S54, S69, S88 and S90). Shown here is the consensus 
nucleotide sequence. The -35 and -10 promoter elements are underlined and the TSS mapped to a G 
residue 164 bases upstream of the GTG start codon (indicated by the curved arrow).  
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Fig. 4. Contribution of FimE and FimX to fimS inversion and type 1 fimbriae expression in EC958.  
Western blots demonstrating expression of the FimA major subunit protein of type 1 fimbriae using α-FimA 
antibody and yeast cell agglutination assays to monitor type 1 fimbriae expression (- negative, + positive 
fimbriae expression) in static cultures.  
A. Type 1 fimbriae expression was measured in EC958 (wild-type), EC958fimE, EC958fimX, and EC958fimE 
fimX over 5 days of static subculture.  
B. Type 1 fimbriae expression in EC958fimE fimX strains over 3 days of static subculture. EC958fimE fimX 
(pSU2718) was used as an empty vector control. Over-expression of FimE (pFimE) and FimX (pFimX) was 
induced by the addition of 1mM IPTG to the culture media.  
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Fig. 5. Quantification of fimS switch orientation bias in EC958 wild-type, mutants and complemented strains 
using DISCus.  
A. fimS orientation in EC958, EC958fimE, EC958fimX and EC958fimE fimX over 5 days of static subculture 
quantified using DISCus. Samples from the air-liquid interface of each culture were taken on each day and 
used for genomic DNA extraction and Illumina sequencing. Bars represent fimS percentage ‘on’ population 
within each culture.  
B. DISCus analysis of fimS orientation following in trans complementation with FimE (pFimE) or FimX 
(pFimE) in the EC958fimE fimX double mutant over 3 days of static subculture.  
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Fig. 6. Quantification of fimX switch orientation bias in EC958 wild-type, mutants and complemented strains 
using DISCus.  
A. DISCus analysis of fimX switch orientation in EC958, EC958fimE and EC958fimX strains over 5 days of 
static subculture. Bars represent percentage fimX switch ‘on’ reads within each culture population.  
B. DISCus analysis of fimX switch orientation in EC958fimE fimX and in EC958fimE fimX following in trans 
complementation with FimE (pFimE) or FimX (pFimE) over 3 days of static subculture.  
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Fig. 7. Effect of hns deletion on fimE transcript level in different UPEC strains.  
A. Fold-change in fimE transcription in EC958hns compared to wild-type EC958 as determined by qRT-PCR.  
B-D. Fold-change in fimE transcription in non-ST131 wild-type UPEC strains and their corresponding hns 
deletion mutants, namely UTI89 (B), 536 (C) and IHE3034 (D) as determined by qRT-PCR. Vertical bars 
represent means±SD of three independent replicates.  
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Fig. 8. Effect of guaB deletion on fimE/fimX promoter activity and fimS switching in EC958.  
A-B. β-galactosidase activity of EC958 fimE (A) and fimX (B) promoter-lacZ reporter strains following 
overnight aerated growth in pooled human urine. All guaB mutant strains and complemented derivatives 
were constructed in their respective promoter-lacZ reporter backgrounds. Bars represent means ± SD of at 
least three independent biological experiments. Asterisk indicates a statistically significant difference 
(P<0.05) as determined by repeated-measures one-way ANOVA with Dunnett’s multiple comparisons test.  
C. DISCus analysis of the effect of guaB deletion on fimS switching. EC958  
(wild-type), EC958guaB and EC958guaB(pGuaB) were grown statically in LB (37oC) over a period of 5 days. 
Over-expression of GuaB in EC958guaB(pGuaB) was induced by the addition of 1mM IPTG. Genomic DNA 
was extracted after static subculture on days 1, 3 and 5, and Illumina sequencing data was analyzed by 
DISCus. Bars represent percentage ‘on’ reads of fimS in each culture population. Asterisks indicate a 
statistically significant difference (* P = 0.01-0.001; *** P < 0.0001) as determined by a Pearson’s χ2 test 
with Yates’ continuity correction.  
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Fig. 9. Regulation of fimE and fimX promoter activity by (p)ppGpp.  
A-B. Effect of serine hydroxamate (SHX, 0.2 mM) induced amino acid starvation on the promoter activity of 
fimE (A) and fimX (B) in EC958fimE:lacZ and EC958fimX:lacZ strains, respectively. All guaB mutant strains 
and complemented derivatives were constructed in their respective promoter-lacZ reporter backgrounds. 
Strains were incubated overnight under static conditions in pooled human urine and promoter activity was 
determined by the β-galactosidase assay. Bars represent means ± SD of three independent biological 
experiments with four technical replicates. Asterisk indicates a statistically significant difference (P<0.05) as 
determined by the Wilcoxon matched pairs signed-rank test.  
C-D. Effect of GTP (0.5 mM) on the promoter activity of fimE (C) and fimX (D) in EC958fimE::lacZ guaB and 
EC958fimX::lacZ guaB strains, respectively. Asterisks indicate statistically significant differences (**P<0.01, 
*P<0.05) in guaB reporter strains upon addition of GTP, as determined by a repeated-measures one-way 
ANOVA with Dunnett’s multiple comparisons test.  
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Fig. 10. Mouse urinary tract colonization by EC958 WT and EC958guaB. Female C57B/L6 mice were 
transurethrally inoculated with a 1:1 mixture of type 1 fimbriae enriched EC958 WT and EC958guaB strains 
in a competitive infection assay. Each marker represents total colony forming units (CFU) recovered from 
each mouse per 1 ml of urine or per 0.1 g of bladder tissue (as labelled) on selective medium. Lines connect 
data points for the same mouse and horizontal bars represent median values. Asterisk indicates statistically 
significant difference between the strains for persistence in urine (P<0.05) as well as bladder colonization 
(P<0.01) as determined by the Wilcoxon matched pairs signed-rank test.  
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